financetom
Business
financetom
/
Business
/
FLINT Announces Fourth Quarter And 2023 Annual Financial Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FLINT Announces Fourth Quarter And 2023 Annual Financial Results
Mar 12, 2024 2:59 PM

05:30 PM EDT, 03/12/2024 (MT Newswires) -- FLINT Corp. ( NWPIF ) Tuesday announced its results for the three and twelve months ending Dec. 31, 2023, $300,000 representing a decrease of $4.6 million or 94.7% from the same period in 2022.

"2023 was the second consecutive year of record annual revenues for FLINT at $655.7 million, representing an increase of 8.4% over 2022. These results were driven primarily by our Maintenance and Construction Services segment which benefited from our organic growth strategy that targets both industrial end market and geographic diversification," said Barry Card, Chief Executive Officer, in a statement. "We have seen strong bookings to start 2024 with new contract awards and renewals during the first two months that are estimated to generate approximately $169.6 million in backlog. The awarded work will be executed across Energy and Industrial markets, including oil and gas, agriculture and forestry."

Gross profit for the year ended Dec. 31, 2023 was $67.5 million, representing an increase of $4.4 million or 6.9% from 2022. The increase in gross profit was primarily driven by an increase in the volume of work in the Maintenance and Construction Services segment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mersana Therapeutics' XMT-1660 Gains Additional US FDA Fast Track Designation
Mersana Therapeutics' XMT-1660 Gains Additional US FDA Fast Track Designation
Jan 10, 2025
06:58 AM EST, 01/10/2025 (MT Newswires) -- Mersana Therapeutics ( MRSN ) said Friday that the US Food and Drug Administration recently granted an additional Fast Track designation to XMT-1660 for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or HER2-negative disease, including triple-negative breast cancer, who have received a...
Constellation Energy buys Calpine in $26.6 bln deal
Constellation Energy buys Calpine in $26.6 bln deal
Jan 10, 2025
Jan 10 (Reuters) - Constellation Energy ( CEG ) said on Friday it would buy privately held Calpine Corp, a geothermal and natgas energy company, in a cash-and-stock deal valued at $26.6 billion including debt. ...
Peru's Central Bank Cuts Policy Rate by 25bps, Notes BBVA Research
Peru's Central Bank Cuts Policy Rate by 25bps, Notes BBVA Research
Jan 10, 2025
06:54 AM EST, 01/10/2025 (MT Newswires) -- The Board of Peru's central bank (BCRP) decided to cut the policy rate by 25 basis points to 4.75% late Thursday, noted BBVA Research. BCRP expects headline and core inflation to remain close to the center of the target range -- 2%, more or less 1% -- in the following months. One year...
Market Chatter: Kinder Morgan Shuts Two Los Angeles Fuel Pipelines Amid Power Outages From Wildfires
Market Chatter: Kinder Morgan Shuts Two Los Angeles Fuel Pipelines Amid Power Outages From Wildfires
Jan 10, 2025
06:53 AM EST, 01/10/2025 (MT Newswires) -- Kinder Morgan ( KMI ) temporarily shut down its SFPP West and CALNEV fuel pipelines in Los Angeles on Jan. 8 due to power outages caused by the wildfires, Reuters reported Friday, citing the pipeline operator. According to the report, the pipelines are not directly impacted by the fires, and service is expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved